503A GLP-1 Compounding Compliance, Trends, and Risks: Today, Tomorrow, and the Future

As demand for GLP-1s continues to rise, so do the legal and regulatory challenges for 503A compounders, prescribers, and other stakeholders. In this webinar, Frier Levitt attorneys Arielle Miliambro and Martha Rumore break down the latest developments and offer strategic insights for navigating this complex and evolving landscape. What You'll Learn: 🔸Strategies for navigating the rapidly changing GLP-1 regulatory environment 🔸Legal insights into recent lawsuits involving medical necessity and the corporate practice of medicine (CPOM) 🔸Emerging GLP-1 formulations and what they mean for compounders 🔸The growing influence of insurers, PBMs, and payers in a shifting market 🔸Key legal and compliance considerations for clinicians prescribing GLP-1 therapies Don’t miss this essential discussion for anyone involved in compounding, prescribing, or managing GLP-1-related care. 👉 Subscribe for more updates on compounding, legal insights, and regulatory changes! 🌐Visit our website to access the full series: https://www.frierlevitt.com/navigatin... Have questions? Contact Frier Levitt’s legal team for guidance: www.frierlevitt.com #frierlevitt #GLP1 #CompoundingCompliance #HealthcareLaw #PharmacyLaw #PBM #503A #TelehealthLaw #RegulatoryUpdates